LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 92.25 | 27.76 | 1737 | 6873 | 0.2527 | 0.6823 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 93.96 | 27.76 | 1238 | 6849 | 0.1808 | 0.6127 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 93.96 | 27.76 | 1249 | 6849 | 0.1824 | 0.6145 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 93.96 | 27.76 | 256 | 6849 | 0.0374 | 0.3226 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 93.96 | 27.76 | 1769 | 6849 | 0.2583 | 0.6868 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 95.66 | 27.76 | 1261 | 6712 | 0.1879 | 0.6193 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 95.66 | 27.76 | 1274 | 6712 | 0.1898 | 0.6214 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 95.66 | 27.76 | 266 | 6712 | 0.0396 | 0.3303 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 95.66 | 27.76 | 1785 | 6712 | 0.2659 | 0.6919 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 1.95 | 27.76 | 613 | 225 | 2.7227 | 1.7866 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 1.95 | 27.76 | 634 | 225 | 2.8160 | 1.8179 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 3.66 | 27.76 | 3 | 283 | 0.0106 | -0.4848 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 3.66 | 27.76 | 657 | 283 | 2.3140 | 1.5683 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 3.66 | 27.76 | 730 | 283 | 2.5711 | 1.6503 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 5.36 | 27.76 | 2 | 320 | 0.0062 | -0.5255 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 5.36 | 27.76 | 743 | 320 | 2.3193 | 1.5385 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 5.36 | 27.76 | 789 | 320 | 2.4629 | 1.5820 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 7.06 | 27.76 | 3 | 360 | 0.0083 | -0.4522 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 7.06 | 27.76 | 820 | 360 | 2.2778 | 1.4988 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 7.06 | 27.76 | 2 | 360 | 0.0056 | -0.5091 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 7.06 | 27.76 | 880 | 360 | 2.4444 | 1.5470 | MN20160318_Q01 | L05 |